tiprankstipranks
Trending News
More News >

Sinco Pharmaceuticals Announces 2025 Annual General Meeting Agenda

Story Highlights
Sinco Pharmaceuticals Announces 2025 Annual General Meeting Agenda

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ).

Sinco Pharmaceuticals Holdings Ltd. has announced its upcoming annual general meeting scheduled for May 15, 2025, in Kunming City, China. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and approval of a final dividend. These resolutions are expected to impact the company’s governance and financial strategies, potentially influencing shareholder value and market perception.

More about Sinco Pharmaceuticals Holdings Ltd.

Sinco Pharmaceuticals Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is incorporated under the laws of the Cayman Islands and is listed on the Hong Kong Stock Exchange.

YTD Price Performance: -10.50%

Average Trading Volume: 540,071

Technical Sentiment Signal: Buy

Current Market Cap: HK$363.9M

See more insights into 6833 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1